Breast Cancer in Men

N Engl J Med. 2018 Jun 14;378(24):2311-2320. doi: 10.1056/NEJMra1707939.
No abstract available

Publication types

  • Review

MeSH terms

  • Aftercare
  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Aromatase Inhibitors / therapeutic use
  • Breast Neoplasms, Male* / diagnosis
  • Breast Neoplasms, Male* / drug therapy
  • Breast Neoplasms, Male* / genetics
  • Breast Neoplasms, Male* / surgery
  • Chemotherapy, Adjuvant
  • Diagnosis, Differential
  • Genes, BRCA1
  • Genes, BRCA2
  • Humans
  • Male
  • Mutation
  • Prognosis
  • Risk Factors
  • Tamoxifen / adverse effects
  • Tamoxifen / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Tamoxifen